Literature DB >> 19108798

Dosage form design and development.

Loyd V Allen1.   

Abstract

BACKGROUND: Drugs must be properly formulated for administration to patients, regardless of age. Pediatric patients provide some additional challenges to the formulator in terms of compliance and therapeutic efficacy. Due to the lack of sufficient drug products for the pediatric population, the pharmaceutical industry and compounding pharmacies must develop and provide appropriate medications designed for children.
OBJECTIVE: The purpose of this article was to review the physical, chemical, and biological characteristics of drug substances and pharmaceutical ingredients to be used in preparing a drug product. In addition, stability, appearance, palatability, flavoring, sweetening, coloring, preservation, packaging, and storage are discussed.
METHODS: Information for the current article was gathered from a literature review; from presentations at professional and technical meetings; and from lectures, books, and publications of the author, as well as from his professional experience. Professional society meetings and standards-setting bodies were also used as a resource.
RESULTS: The proper design and formulation of a dosage form requires consideration of the physical, chemical, and biological characteristics of all of the drug substances and pharmaceutical ingredients (excipients) to be used in fabricating the product. The drug and pharmaceutical materials utilized must be compatible and produce a drug product that is stable, efficacious, palatable, easy to administer, and well tolerated. Preformulation factors include physical properties such as particle size, crystalline structure, melting point, solubility, partition coefficient, dissolution, membrane permeability, dissociation constants, and drug stability.
CONCLUSIONS: Successful development of a formulation includes multiple considerations involving the drug, excipients, compliance, storage, packaging, and stability, as well as patient considerations of taste, appearance, and palatability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108798     DOI: 10.1016/j.clinthera.2008.11.015

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  11 in total

1.  Relationship between bitter-taste receptor genotype and solid medication formulation usage among young children: a retrospective analysis.

Authors:  Sarah V Lipchock; Danielle R Reed; Julie A Mennella
Journal:  Clin Ther       Date:  2012-03       Impact factor: 3.393

Review 2.  The bad taste of medicines: overview of basic research on bitter taste.

Authors:  Julie A Mennella; Alan C Spector; Danielle R Reed; Susan E Coldwell
Journal:  Clin Ther       Date:  2013-07-22       Impact factor: 3.393

Review 3.  Bioidentical hormone therapy.

Authors:  Julia A Files; Marcia G Ko; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-04-29       Impact factor: 7.616

Review 4.  Foundations of gastrointestinal-based drug delivery and future developments.

Authors:  Jacqueline N Chu; Giovanni Traverso
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-16       Impact factor: 46.802

5.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

6.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

7.  Children's perceptions about medicines: individual differences and taste.

Authors:  Julie A Mennella; Kristi M Roberts; Phoebe S Mathew; Danielle R Reed
Journal:  BMC Pediatr       Date:  2015-09-21       Impact factor: 2.125

Review 8.  Oral Dispersible System: A New Approach in Drug Delivery System.

Authors:  P A Hannan; J A Khan; A Khan; S Safiullah
Journal:  Indian J Pharm Sci       Date:  2016 Jan-Feb       Impact factor: 0.975

Review 9.  Sweetener content and cariogenic potential of pediatric oral medications: A literature.

Authors:  Jehan Al Humaid
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun

Review 10.  Patient adherence to multivitamin supplementation after bariatric surgery: a narrative review.

Authors:  Hendrika J M Smelt; Sjaak Pouwels; Johannes F Smulders; Eric J Hazebroek
Journal:  J Nutr Sci       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.